Cargando…
Profile of the Nicotinic Cholinergic Receptor Alpha 7 Subunit Gene Expression is Associated with Response to Varenicline Treatment
Introduction: Smoking is considered the leading cause of preventable morbidity and mortality worldwide. Studies have sought to identify predictors of response to smoking cessation treatments. The aim of this study was to analyze a possible association of target gene expression for smoking cessation...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397196/ https://www.ncbi.nlm.nih.gov/pubmed/32640505 http://dx.doi.org/10.3390/genes11070746 |
_version_ | 1783565725088088064 |
---|---|
author | Santos, Juliana Rocha Tomaz, Paulo Roberto Xavier Scholz, Jaqueline Ribeiro Gaya, Patrícia Viviane Abe, Tânia Ogawa Krieger, José Eduardo Pereira, Alexandre Costa Santos, Paulo Caleb Júnior de Lima |
author_facet | Santos, Juliana Rocha Tomaz, Paulo Roberto Xavier Scholz, Jaqueline Ribeiro Gaya, Patrícia Viviane Abe, Tânia Ogawa Krieger, José Eduardo Pereira, Alexandre Costa Santos, Paulo Caleb Júnior de Lima |
author_sort | Santos, Juliana Rocha |
collection | PubMed |
description | Introduction: Smoking is considered the leading cause of preventable morbidity and mortality worldwide. Studies have sought to identify predictors of response to smoking cessation treatments. The aim of this study was to analyze a possible association of target gene expression for smoking cessation with varenicline. Methods: We included 74 smokers starting treatment with varenicline. Gene expression analysis was performed through the custom RT² Profiler qPCR array assay, including 17 genes. Times for sample collection were before the start of therapy (T0) and two weeks (T2) and four weeks (T4) after the start of treatment. Results: For gene expression analysis, we selected 14 patients who had success and 13 patients resistant to varenicline treatment. Success was considered to be when a patient achieved tobacco abstinence until the fourth week of treatment and resistant was when a patient had not stopped smoking as of the fourth week of treatment. We observed a significant difference for CHRNA7 gene expression: in the resistant group, samples from T2 and T4 had lower expression compared with T0 (fold change: 0.38, P = 0.007; fold change: 0.67, P = 0.004; respectively). Conclusion: This exploratory clinical study, searching for a possible predictor of effectiveness for varenicline, reaffirmed the association of the α7 nAChR subunit for nicotine dependence and smoking therapy effectiveness with varenicline. |
format | Online Article Text |
id | pubmed-7397196 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73971962020-08-16 Profile of the Nicotinic Cholinergic Receptor Alpha 7 Subunit Gene Expression is Associated with Response to Varenicline Treatment Santos, Juliana Rocha Tomaz, Paulo Roberto Xavier Scholz, Jaqueline Ribeiro Gaya, Patrícia Viviane Abe, Tânia Ogawa Krieger, José Eduardo Pereira, Alexandre Costa Santos, Paulo Caleb Júnior de Lima Genes (Basel) Article Introduction: Smoking is considered the leading cause of preventable morbidity and mortality worldwide. Studies have sought to identify predictors of response to smoking cessation treatments. The aim of this study was to analyze a possible association of target gene expression for smoking cessation with varenicline. Methods: We included 74 smokers starting treatment with varenicline. Gene expression analysis was performed through the custom RT² Profiler qPCR array assay, including 17 genes. Times for sample collection were before the start of therapy (T0) and two weeks (T2) and four weeks (T4) after the start of treatment. Results: For gene expression analysis, we selected 14 patients who had success and 13 patients resistant to varenicline treatment. Success was considered to be when a patient achieved tobacco abstinence until the fourth week of treatment and resistant was when a patient had not stopped smoking as of the fourth week of treatment. We observed a significant difference for CHRNA7 gene expression: in the resistant group, samples from T2 and T4 had lower expression compared with T0 (fold change: 0.38, P = 0.007; fold change: 0.67, P = 0.004; respectively). Conclusion: This exploratory clinical study, searching for a possible predictor of effectiveness for varenicline, reaffirmed the association of the α7 nAChR subunit for nicotine dependence and smoking therapy effectiveness with varenicline. MDPI 2020-07-06 /pmc/articles/PMC7397196/ /pubmed/32640505 http://dx.doi.org/10.3390/genes11070746 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Santos, Juliana Rocha Tomaz, Paulo Roberto Xavier Scholz, Jaqueline Ribeiro Gaya, Patrícia Viviane Abe, Tânia Ogawa Krieger, José Eduardo Pereira, Alexandre Costa Santos, Paulo Caleb Júnior de Lima Profile of the Nicotinic Cholinergic Receptor Alpha 7 Subunit Gene Expression is Associated with Response to Varenicline Treatment |
title | Profile of the Nicotinic Cholinergic Receptor Alpha 7 Subunit Gene Expression is Associated with Response to Varenicline Treatment |
title_full | Profile of the Nicotinic Cholinergic Receptor Alpha 7 Subunit Gene Expression is Associated with Response to Varenicline Treatment |
title_fullStr | Profile of the Nicotinic Cholinergic Receptor Alpha 7 Subunit Gene Expression is Associated with Response to Varenicline Treatment |
title_full_unstemmed | Profile of the Nicotinic Cholinergic Receptor Alpha 7 Subunit Gene Expression is Associated with Response to Varenicline Treatment |
title_short | Profile of the Nicotinic Cholinergic Receptor Alpha 7 Subunit Gene Expression is Associated with Response to Varenicline Treatment |
title_sort | profile of the nicotinic cholinergic receptor alpha 7 subunit gene expression is associated with response to varenicline treatment |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397196/ https://www.ncbi.nlm.nih.gov/pubmed/32640505 http://dx.doi.org/10.3390/genes11070746 |
work_keys_str_mv | AT santosjulianarocha profileofthenicotiniccholinergicreceptoralpha7subunitgeneexpressionisassociatedwithresponsetovareniclinetreatment AT tomazpaulorobertoxavier profileofthenicotiniccholinergicreceptoralpha7subunitgeneexpressionisassociatedwithresponsetovareniclinetreatment AT scholzjaquelineribeiro profileofthenicotiniccholinergicreceptoralpha7subunitgeneexpressionisassociatedwithresponsetovareniclinetreatment AT gayapatriciaviviane profileofthenicotiniccholinergicreceptoralpha7subunitgeneexpressionisassociatedwithresponsetovareniclinetreatment AT abetaniaogawa profileofthenicotiniccholinergicreceptoralpha7subunitgeneexpressionisassociatedwithresponsetovareniclinetreatment AT kriegerjoseeduardo profileofthenicotiniccholinergicreceptoralpha7subunitgeneexpressionisassociatedwithresponsetovareniclinetreatment AT pereiraalexandrecosta profileofthenicotiniccholinergicreceptoralpha7subunitgeneexpressionisassociatedwithresponsetovareniclinetreatment AT santospaulocalebjuniordelima profileofthenicotiniccholinergicreceptoralpha7subunitgeneexpressionisassociatedwithresponsetovareniclinetreatment |